Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 1998, Pages 172-177

  Acerbi, D ^a   Poli, G ^a   Ventura, P ^a  

^a CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Bioavailability; Healthy subjects; Ipriflavone; Pharmacokinetics; Scherer capsules

Indexed keywords

IPRIFLAVONE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG FORMULATION; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; TABLET;

EID: 0031712418     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189335     Document Type: Conference Paper

References (8)

1. Passeri M., et al. (1992): Effect of ipriflavone on bone mass in elderly osteoporotic women. Bone&Min., 19 (Suppl. 1), s57-s62.
2. Saito M. (1985): Pharmacokinetic study of ipriflavone by oral administration in healthy male volunteers. Jpn. Pharm. Ther., 13, 7223-7233.
3. Levy G., Jusko W.J. (1966): Factors affecting the absorption of riboflavin in man. J. Pharm. Sci., 55, 285-289.
4. Gomeni R. (1983): An interactive program for individual and population parameter estimation. In: Von Bommel, M.J. Ball, N.O. Wigerts (eds), Medinfo 83, Elsevier, North Holland.
5. Fleiss J.L. (1986): The design and analysis of clinical experiments. Wiley Interscience, New York.
6. Steinijans V.W., Hauschke D. (1990): Update on the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol., 28, 105-110.
7. Chow S.C., Liu J.P. (1992): Design and analysis of bioavailability and bioequivalence studies. Marcel Dekker, New York.
8. Metzler C.M. (1988): Statistical methods for deciding bioequivalence of formulations. In: Yacobi A., HHalperin-Walega(eds), Oral sustained release formulations: Design and evaluation. Pergamon Press, New York.